This article originally appeared in the Catalyst on February 15, 2019.
“Preventative medicine” is a great idea, except for the small caveat that the concept has saved few lives at a substantial cost. For example, according to researchers at the Harvard School of Public Health and Tufts–New England Medical Center, screening all 65-year-olds for diabetes (as opposed to screening only 65-year-olds with hypertension for diabetes) costs hundreds of thousands of dollars for each year of life saved. But what if a one-time shot early in life could prevent diseases such as diabetes altogether, saving countless lives and health care dollars? Fortunately, a new line of treatment—gene replacement therapy—offers the game-changing benefits to patients that doctors could only dream of a decade ago. And, this new technology could save taxpayers billions of dollars. » Read Blog